Cefratam powder

Dexa Medica

Ingredients in every vial

Cefoperazone 1000 mg
Sulbactam 500 mg

Each package contains

1 vial of 1 g

Other details

Dosage form:Powder for Injection
Flavour: None

W.H.O. classification

ATC Level 1: J - Antiinfectives for systemic use
ATC Level 2: J01 - Antibacterials for Systemic Use
ATC Level 3: J01D - Other Beta-Lactam Antibacterials in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

CAUTIONThis item may not be safe for use during lactation. Use with caution.

Alcohol

NOT SAFEThis item should not be used with alcohol.

Machinery

SAFE IF PRESCRIBEDThis item is safe for use while operating heavy machinery.

Available in

Indonesia
Cambodia

Dosage information

UP TO 18 YEARS OLD
Daily dosage recommendations for CEFRATAM in children are 40-80 mg/kg/day.
Doses should be administered every 6 to 12 hours in equally divided doses.

In serious or refractory infections, these dosages may be increased up to 160 mg/kg/day of the 1:1 ratio. Doses should be administered in two to four equally divided doses.

18 YEARS OLD AND ABOVE
Daily dosage recommendations for CEFRATAM in adults are 2-4 g.
Doses should be administered every 12 hours in equally divided doses.

In severe or refractory infections, the daily dosage of CEFRATAM may be increased up to 8 g with the ratio 1:1 (i.e., 4g cefoperazone activity). Patients who receive the 1:1 ratio may require additional cefoperazone administered separately. Doses should be administered every 12 hours in equally divided doses.
The recommended maximum daily dosage of sulbactam is 4g.

HEPATIC DYSFUNCTION
Dose modification may be necessary in cases of severe biliary obstruction, severe hepatic disease or in cases of renal dysfunction coexistent with either of those conditions. In patients with hepatic dysfunction and concomitant renal impairment, cefoperazone serum concentrations should be monitored and dosage adjusted as necessary. In these cases dosage should not exceed 2 g/day of cefoperazone.

RENAL DYSFUNCTION
Dosage regimens of CEFRATAM should be adjusted in patients with marked decrease in renal function (creatinine clearance of less than 30 ml/min) to compensate for the reduced clearance of sulbactam. Dosage adjusment for CEFRATAM as follows:
– Patients with creatinine clearances less than 15 ml/min should receive a maximum of 500 mg of sulbactam every 12 hours (maximum daily dosage of 1 g sulbactam)
– Patients with creatinine clearances between 15 and 30 ml/min should receive a maximum of 1 g of sulbactam administered every 12 hours (maximum daily dosage of 2 g sulbactam)

In severe infections, it may be necessary to administer additional cefoperazone. The pharmacokinetic profile of sulbactam is significantly altered by hemodialysis. The serum half-life of cefoperazone is reduced slightly during hemodialysis. Thus, dosing should be scheduled to follow a dialysis period.

NEONATES
For neonates in the first week of life, CEFRATAM should be given every 12 hours. The maximum daily dosage of sulbactam in pediatrics should not exceed 80 mg/kg/day. For doses of CEFRATAM requiring more than 80 mg/kg/day cefoperazone activity, additional cefoperazone should be administered separately.

Indication

Monotherapy
Cefratam is indicated for the treatment of the following infections when caused by susceptible organisms:
– Upper and lower respiratory tract infections
– Upper and lower urinary tract infections
– Peritonitis, cholecystitis, cholangitis, and others intra-abdominal infections
– Skin and soft tissue infections

Combination therapy
Because of the broad spectrum of activity of Cefratam, most infections can be treated adequately with this antibiotic alone. However, Cefratam may be used concomitantly with other antibiotics if such combinations are indicated. If an aminoglycoside is used (see section Incompatibilities aminoglycoside), renal function should be monitored during the course of therapy (see section dosage and administration in renal dysfunction).

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.